RecruitingNCT07425730
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
Myocardial Dysfunction in Pediatric Lupus
Sponsor
Shanghai Jiao Tong University School of Medicine
Enrollment
60 participants
Start Date
Feb 1, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
To investigate biomarkers to identify pediatric SR-SLE patients by non-invasive echocardiographic techniques.
Eligibility
Min Age: 7 YearsMax Age: 17 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with systemic lupus erythematosus (sle). The study is currently recruiting participants at 1 location. People eligible for this study include aged 7 Years to 17 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07425730
Related Trials
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
NCT055671981 location
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
NCT068399761 location
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT0717528564 locations
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
NCT060329231 location
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
NCT0633597913 locations